SignatureFD
HCAT icon

SignatureFD’s Health Catalyst HCAT Stock Holding History

SignatureFD’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$125 Hold
72
– – ﹤0.01% 3489
2026
Q2 		$143 Hold
72
– – ﹤0.01% 3433
2026
Q1 		$91 Hold
72
– – ﹤0.01% 3399
2025
Q4 		$172 Hold
72
– – ﹤0.01% 3309
2025
Q3 		$205 Hold
72
– – ﹤0.01% 3273
2025
Q2 		$271 Hold
72
– – ﹤0.01% 3165
2025
Q1 		$326 Hold
72
– – ﹤0.01% 3215
2024
Q4 		$509 Sell
72
-64
-47% -$510 ﹤0.01% 3138
2024
Q3 		$1.11K Buy
136
+64
+89% +$462 ﹤0.01% 2980
2024
Q2 		$460 Hold
72
– – ﹤0.01% 2993
2024
Q1 		$542 Sell
72
-41
-36% -$374 ﹤0.01% 3019
2023
Q4 		$1.05K Sell
113
-626
-85% -$5.12K ﹤0.01% 2897
2023
Q3 		$7.48K Sell
739
-353
-32% -$4.21K ﹤0.01% 2347
2023
Q2 		$13.6K Sell
1,092
-660
-38% -$7.86K ﹤0.01% 2093
2023
Q1 		$20.4K Sell
1,752
-383
-18% -$4.88K ﹤0.01% 1859
2022
Q4 		$22.7K Buy
2,135
+1,222
+134% +$11.8K ﹤0.01% 1750
2022
Q3 		$9K Sell
913
-638
-41% -$8.45K ﹤0.01% 2126
2022
Q2 		$22K Buy
1,551
+815
+111% +$13.9K ﹤0.01% 1716
2022
Q1 		$19K Buy
736
+121
+20% +$3.43K ﹤0.01% 1856
2021
Q4 		$24K Buy
615
+74
+14% +$3.37K ﹤0.01% 1710
2021
Q3 		$27K Buy
541
+12
+2% +$654 ﹤0.01% 1616
2021
Q2 		$29K Buy
529
+10
+2% +$533 ﹤0.01% 1555
2021
Q1 		$24K Sell
519
-21
-4% -$1.02K ﹤0.01% 1503
2020
Q4 		$24K Hold
540
– – ﹤0.01% 1375
2020
Q3 		$20K Sell
540
-50
-8% -$1.7K ﹤0.01% 1367
2020
Q2 		$17K Buy
590
+90
+18% +$2.49K ﹤0.01% 1389
2020
Q1 		$13K Hold
500
– – ﹤0.01% 1393
2019
Q4 		$17K Hold
500
– – ﹤0.01% 1325
2019
Q3 		$16K Buy
+500
New +$19.7K ﹤0.01% 1298

Other funds holding HCAT

Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $13B AUM 14.15% 1-Year Est. Return
Nepsis Inc
Nepsis Inc Minneapolis, Minnesota $317M AUM 37.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1.11B AUM 20.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
71 West Capital Partners
71 West Capital Partners Boston, Massachusetts $3.06B AUM 23.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

SignatureFD's HCAT Position: Q3 2026 in Review

SignatureFD held its Health Catalyst (HCAT) position steady in Q3 2026 at 72 shares worth $125. The position accounts for ﹤0.01% of the portfolio, ranked #3489.

SignatureFD first reported a position in HCAT in Q3 2019 and has held it in 29 quarters since. The position peaked at $29K in Q2 2021. 48 funds tracked by Wall St. Rank hold HCAT as of Q3 2026.

  • SignatureFD held 72 shares of Health Catalyst worth $125 as of Q3 2026.
  • SignatureFD left its Health Catalyst share count unchanged in Q3 2026.
  • Health Catalyst made up ﹤0.01% of SignatureFD's portfolio in Q3 2026, its #3489 holding.
  • SignatureFD first reported a position in Health Catalyst in Q3 2019 and has held it in 29 quarters since.
  • SignatureFD's Health Catalyst position peaked at $29K in Q2 2021.
  • 48 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2026.

Based on SignatureFD's 13F filing for Q3 2026, filed 23 Oct 2026.